11-dehydro-TXB2

11-dehydro-txb2 is a lipid of Fatty Acyls (FA) class. 11-dehydro-txb2 is associated with abnormalities such as endothelial dysfunction, Risk factor, cardiovascular, Acute coronary syndrome, thrombocytosis and Chronic ischemic heart disease NOS. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and Lipid Peroxidation. The associated genes with 11-dehydro-TXB2 are PTGS2 gene.

Cross Reference

Introduction

To understand associated biological information of 11-dehydro-TXB2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 11-dehydro-TXB2?

11-dehydro-TXB2 is suspected in endothelial dysfunction, Risk factor, cardiovascular, Acute coronary syndrome, thrombocytosis, Chronic ischemic heart disease NOS, Diabetes Mellitus and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 11-dehydro-TXB2

MeSH term MeSH ID Detail
Hypoalphalipoproteinemias D052456 5 associated lipids
Renal Artery Obstruction D012078 8 associated lipids
Blood Platelet Disorders D001791 12 associated lipids
Death, Sudden, Cardiac D016757 12 associated lipids
Cerebral Hemorrhage D002543 13 associated lipids
Polycythemia Vera D011087 13 associated lipids
Atrial Fibrillation D001281 16 associated lipids
Albuminuria D000419 18 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Cerebrovascular Disorders D002561 25 associated lipids
Per page 10 20 | Total 20

PubChem Associated disorders and diseases

What pathways are associated with 11-dehydro-TXB2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 11-dehydro-TXB2?

There are no associated biomedical information in the current reference collection.

What functions are associated with 11-dehydro-TXB2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 11-dehydro-TXB2?

There are no associated biomedical information in the current reference collection.

What genes are associated with 11-dehydro-TXB2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 11-dehydro-TXB2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 11-dehydro-TXB2

Download all related citations
Per page 10 20 50 100 | Total 289
Authors Title Published Journal PubMed Link
Davì G et al. Thromboxane biosynthesis and platelet function in type II diabetes mellitus. 1990 N. Engl. J. Med. pmid:2345567
Geske FJ et al. AspirinWorks: a new immunologic diagnostic test for monitoring aspirin effect. 2008 Mol Diagn Ther pmid:18288882
Ciabattoni G et al. Radioimmunoassay of 11-dehydrothromboxane B2. 1990 Meth. Enzymol. pmid:2233352
Fitzgerald DJ et al. Thromboxane A2 synthesis in pregnancy-induced hypertension. 1990 Lancet pmid:1969511
Urinary thromboxane metabolites in pre-eclampsia. 1990 Lancet pmid:1971907
Van Geet C et al. Possible platelet contribution to pathogenesis of transient neonatal hyperammonaemia syndrome. 1991 Lancet pmid:1670726
Malini PL et al. Thromboxane antagonism and cough induced by angiotensin-converting-enzyme inhibitor. 1997 Lancet pmid:9217714
Tönshoff B et al. Increased thromboxane biosynthesis in childhood hemolytic uremic syndrome. 1990 Kidney Int. pmid:2111418
Kapłon-Cieślicka A et al. Predictors of high platelet reactivity during aspirin treatment in patients with type 2 diabetes. 2013 Kardiol Pol pmid:24065375
Davì G et al. Platelet activation in obese women: role of inflammation and oxidant stress. 2002 Oct 23-30 JAMA pmid:12387653
Mills JL et al. Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study. 1999 JAMA pmid:10432033
Fritsma GA et al. Monitoring the antiplatelet action of aspirin. 2001 JAAPA pmid:11523339
Thomason J et al. Platelet cyclooxygenase expression in normal dogs. 2011 Sep-Oct J. Vet. Intern. Med. pmid:21985141
Dudley A et al. Cyclooxygenase expression and platelet function in healthy dogs receiving low-dose aspirin. 2013 Jan-Feb J. Vet. Intern. Med. pmid:23278865
Lin JS et al. The change of urinary 11-dehydro-thromboxane B2 and 2,3-dinor-6-keto-prostaglandin F1 alpha in arteriogenic impotence. 1992 J. Urol. pmid:1635125
Hartanto MD et al. Urinary 11-dehydro-thromboxane B₂ and 2,3-dinor-6-keto-prostaglandin-F₁α in healthy post-menopausal and pre-menopausal women receiving aspirin 100 mg. 2012 J. Thromb. Thrombolysis pmid:22311294
Addad F et al. Response variability to aspirin and one-year prediction of vascular events in patients with stable coronary artery disease. 2010 J. Thromb. Thrombolysis pmid:19381450
Olson MT et al. Effect of assay specificity on the association of urine 11-dehydro thromboxane B2 determination with cardiovascular risk. 2012 J. Thromb. Haemost. pmid:23072449
Ferroni P et al. Platelet activation in type 2 diabetes mellitus. 2004 J. Thromb. Haemost. pmid:15304032
De Cristofaro R et al. Lipid and protein oxidation contribute to a prothrombotic state in patients with type 2 diabetes mellitus. 2003 J. Thromb. Haemost. pmid:12871497